Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
19 hedge funds and large institutions have $82.5M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
5% less funds holding
Funds holding: 20 → 19 (-1)
6% less capital invested
Capital invested by funds: $88M → $82.5M (-$5.49M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$478K |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$191K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$77.2K |
| 4 |
FO
FT Options
Chicago,
Illinois
|
+$65.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$885K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$235K |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$106K |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$36.7K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$3K |
NBRV Hedge Fund Activity: Q3 2016 in Review
19 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q3 2016, worth a combined $82.5M — down 6.2% from $88M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NBRV and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Novo Holdings A/S, adding an estimated $478K. The largest seller was Wellington Management Group, cutting an estimated $885K.
- 19 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q3 2016, down from 20 in Q2 2016.
- Funds reported $82.5M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q3 2016, down 6.2% quarter-over-quarter.
- 0 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q3 2016 and 1 closed out, a net change of -1 holder.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q3 2016 was Novo Holdings A/S, an estimated $478K added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q3 2016 was Wellington Management Group, an estimated $885K sold.
Based on aggregated 13F filings for Q3 2016.